topic

191 Expediting MxIF panel development in FFPE for the PhenoCycler platform: the ‘Joker’ panel development kit
Kaitlyn McGrath, Raymond Moore, Roberto Leon Ferre, Cinnie Y Soekojo, Jose Villasboas

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A217-A218; DOI: 10.1136/jitc-2023-SITC2023.0191
192 Clinicopathologic, genomic and immunophenotypic features and outcomes to immune checkpoint inhibitors in patients with mucinous lung adenocarcinoma
Alessandro Di Federico, Biagio Ricciuti, Joao V Alessi, Federica Pecci, Malini M Gandhi, Maisam Makarem, Emma Voligny, Tom Nguyen, Danielle Haradon, Mizuki Nishino, Scott J Rodig, Bruce E Johnson, Lynette M Sholl, Mark M Awad, Jia Luo

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A219-A220; DOI: 10.1136/jitc-2023-SITC2023.0192
193 PD-L1 expression in gastroesophageal cancer: A systematic literature review
Zev A Wainberg, Sasan Jahanian, Michelle Sidel

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A221; DOI: 10.1136/jitc-2023-SITC2023.0193
194 Characterization of the pharmacodynamic activity of CLN-619, an anti-MICA/B monoclonal antibody, in patients from an ongoing Phase 1 trial
Irina M Shapiro, Kerry A Whalen, Laura Liu, Tracy Liu, Jennifer S Michaelson, Patrick A Baeuerle, Alexander I Spira, Judy S Wang, Erika Hamilton, Michael Millward, Ana Maria Arance, Victor Moreno, Ignacio Melero, Rafal Stec, Jeffrey A Jones

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A222; DOI: 10.1136/jitc-2023-SITC2023.0194
195 Overcoming the dose-response prediction limitation from bench to clinic for T-cell engagers: using quantitative systems pharmacology (QSP) modelling in the development of CDR404 for solid tumors
Melissa Vrohlings, Drew Marquis, Scott Gruver, Fei Hua, Stephanie Jungmichel, Nadia Sanchez, Ivana Tosevski, Leonardo Borras, Swethajit Biswas

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A223; DOI: 10.1136/jitc-2023-SITC2023.0195
196 Tumor-associated SIRPα expression evaluation in melanoma PDX models via IHC for potential ICI-predictive applications
Xiaolong Tu, Wenjuan Zhou, Likun Zhang, Hongjiang Yu, Cheng Jiang, Henry Li, Annie An

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A224; DOI: 10.1136/jitc-2023-SITC2023.0196
197 Evaluating the performance of immune monitoring laboratories using MHC multimer assay
Kivin Jacobsen, Stephen Haley, Niels M Frandsen, Liselotte Brix

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A225; DOI: 10.1136/jitc-2023-SITC2023.0197
198 Development, validation and concordance of two MAGE-A4 immunohistochemistry (IHC) assays to establish prognostic value of MAGE-A4 expression in synovial sarcoma
Robert Connacher, Konstantinos Avraam, Elizabeth Ross, Mary Schneck, Marian Van Kerckhoven, Sofie Van Rossom, Nicolas Gadot, Armelle Dufresne, Dennis Williams, Tianjiao Wang

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A226; DOI: 10.1136/jitc-2023-SITC2023.0198
199 Quantitative and spatial characteristics of TIL in inflammatory neighborhoods of advanced melanoma tumors
Suhendan Ekmekcioglu, Sungnam Cho, Javier A Gomez, Reham Abdel-Wahab, Salah-Eddine Bentebibel, Noha Abdel-Wahab, Julie M Simon, Jeffrey E Gershenwald, Alexander J Lazar, Jared K Burks, Michael A Davies, Adi Diab

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A227; DOI: 10.1136/jitc-2023-SITC2023.0199
200 DETECT – Cost-effective, high-throughput enrichment of low molecular weight proteins in serum proteomics – insights from a CAR-T therapy trial
Parthiban Periasamy, Kai Soon, Xinru Lim, Yang Wu, Jia Meng, Francesca Lim, Joe Yeong

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A228; DOI: 10.1136/jitc-2023-SITC2023.0200

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages